HLA Monomer Tetramer

MHC reagents for immune monitoring

HLA monomer and Tetramers

CLASS I EASYMER

CLASS I CATALOG

CLASS I CUSTOM

The fastest and most flexibel
way to obtain pMHC

CLASS I EASYMER

CLASS I CATALOG

CLASS I CUSTOM

Ready to use peptide-MHC class I
mono- or Tetramers with
known epitopes

Custom generation of peptide-MHC
class I complexes with your
choice of peptide

WE ARE CURRENTLY EXPERIENCING
TECHNICAL PROBLEMS WITH
OUR WEBSITE. WE SHOULD
BE UP AND RUNNING
AGAIN WITHIN A DAY.

WE APOLOGISE FOR
THE INCONVINIENCE

CLASS II CATALOG

CLASS II CUSTOM

WELCOME TO IMMUNAWARE

CLASS I & II SERVICES

Our mission is to provide researchers
all over the world with reagents
and services related to major
histocompatibility complex (MHC)
class I and II molecules.

Read more about us >>

Ready to use peptide-MHC
class II mono- or Tetramers
with known epitope.

Custom generation of peptide-MHC
class II complexes with your
choice of peptide

CLASS II CATALOG

CLASS II CUSTOM

Affinity and stability measurements
of peptide-MHC interactions

CLASS I & II SERVICES

HLA-A*01:01 HLA-A*02:01 HLA-A*02:03 HLA-A*02:11 HLA-A*02:19 HLA-A*03:01 HLA-A*11:01 HLA-A*23:01 HLA-A*24:02 HLA-A*24:03 HLA-A*24:07 HLA-A*25:01 HLA-A*26:01 HLA-A*26:03 HLA-A*29:02 HLA-A*30:01 HLA-A*30:02 HLA-A*32:01 HLA-A*33:03 HLA-A*36:01 HLA-A*66:01 HLA-A*68:01 HLA-A*68:02 HLA-A*74:01 HLA-B*07:02 HLA-B*08:01 HLA-B*13:01 HLA-B*13:02 HLA-B*14:01 HLA-B*14:02 HLA-B*15:01 HLA-B*15:02 HLA-B*15:03 HLA-B*15:09 HLA-B*15:10 HLA-B*18:01 HLA-B*27:02 HLA-B*27:03 HLA-B*27:05 HLA-B*35:01 HLA-B*35:03 HLA-B*35:05 HLA-B*35:08 HLA-B*37:01 HLA-B*38:01 HLA-B*39:01 HLA-B*39:02 HLA-B*39:06 HLA-B*39:10 HLA-B*40:01 HLA-B*41:01 HLA-B*42:01 HLA-B*42:02 HLA-B*44:02 HLA-B*44:03 HLA-B*46:01 HLA-B*50:01 HLA-B*51:01 HLA-B*52:01 HLA-B*53:01 HLA-B*55:01 HLA-B*56:01 HLA-B*57:01 HLA-B*57:02 HLA-B*57:03 HLA-B*58:01 HLA-B*58:02 HLA-B*81:01 HLA-B*83:01 HLA-C*02:02 HLA-C*03:02 HLA-C*03:03 HLA-C*03:04 HLA-C*05:01 HLA-C*06:02 HLA-C*07:01 HLA-C*07:02 HLA-C*08:01 HLA-C*14:02 HLA-C*15:02 HLA-C*16:01 H-2 Dd H-2 Kb H-2 Kd H-2 Ld H-2 Db

OUR LINKS TO PEPTIDE MHC PREDICTORS

MHC class I affinity predictors

NetMHC

NetMHCpan

MHC class I stability predictors

NetMHCstab

NetMHCstabpan

MHC class II affinity predictors

NetMHCII

NetMHCIIpan

NEWS

The Latest research..
Where easYmer® monomers and Multimers have been used to describe SARS-CoV2 specific T cells and tumor specific neo-epitopes. 1. Oberhardt, V., et al., Rapid and stable mobilization of CD8(+) T cells by SARS-CoV-2 mRNA vaccine. Nature, 2021. 2. Sahin, U., et al., BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature, 2021. 3. Tippalagama, R., et al.,...

Recent Scientific Papers

Oberhardt, V., et al., Rapid and stable mobilization of CD8(+) T cells by SARS-CoV-2 mRNA vaccine. Nature, 2021.
Sahin, U., et al., BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature, 2021.
Bigot, J., et al., Splicing patterns in SF3B1 mutated uveal melanoma generate shared immunogenic tumor-specific neo-epitopes. Cancer Discov, 2021.
Schulien, I., et al., Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells. Nature Medicine, 2021. 27(1): p. 78-85.

easYmer - How to

CONTACT US WITH YOUR INQUIRY

FIND US

Visit our LinkedIn company profile to Follow Us!

We post new HLA monomer and Tetramer additions to our catalog - updates on papers focusing on the use of HLA Tetramers in cell therapy, immuno oncology, vaccine etc.